In melanoma cells, the isoquinoline alkaloid berberine stimulates ROS production which in turn regulates AMPK phosphorylation and activation leading to the decrease of ERK activity and COX-2 expression, finally reducing metastatic capacity of the cells [373]. Here, PTGS2 is linked to melanoma.